Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Alcohol Clin Exp Res. 2008 Jul;32(7):1271–1283. doi: 10.1111/j.1530-0277.2008.00682.x

Fig. 3.

Fig. 3

Percentage of individuals who were totally abstinent (A), relapsed to a heavy drinking day (B) or reported alcohol-related problems on the DriInC (C) during the 16-week treatment period by treatment condition within participants who were homozygous for the Asn40 allele (n = 75), carriers of the Asp40 allele (N = 17), and for the total sample of genotyped participants (n = 92).